Royal Philips (PHG) announced the expansion of its partnership with Ibex Medical Analytics and a new release of Philips IntelliSite Pathology Solution to further accelerate the adoption of AI ...

Health technology company Royal Philips has expanded its partnership with Ibex Medical Analytics that includes a new release of the Philips IntelliSite Pathology Solution (PIPS) to speed up adoption ...

Amsterdam, The Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex ...

Broadcaster GP Dr Sarah Jarvis is chief medical advisor to the firm and says screening for osteoporosis is so far "grossly ...

The Galen Prostate AI – developed by Ibex Medical Analytics – became the first AI-based cancer diagnostic to be given a CE Mark in the EU earlier this year under the In Vitro Diagnostic ...

Enhanced Diagnostic Accuracy and Efficiency Ibex's AI and Philips’ digital pathology solution have shown to improve reporting efficiency and drive productivity gains of up to 37% [1]. Through ...

Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex) and a new ...